Merckserono United Kingdom Website
Merck Group Website

Media

Merck Serono is the division for innovative prescription pharmaceuticals of Merck, a global pharmaceutical and chemical group. Headquartered in Geneva, Switzerland, Merck Serono discovers, develops, manufactures and markets innovative small molecules and biopharmaceuticals to help patients with unmet medical needs. Its North American business operates in the United States and Canada as EMD Serono.
Merck Serono has leading brands serving patients with cancer, multiple sclerosis, infertility, endocrine and cardiometabolic disorders.
With an annual R&D investment of around € 1bn, Merck Serono is committed to growing its business in specialist-focused therapeutic areas including neurodegenerative diseases,  oncology, fertility and endocrinology, as well as new areas potentially arising out of research and development in autoimmune and inflammatory diseases.

MERCK SERONO UK HEADQUARTERS

Merck Serono Ltd
Bedfont Cross
Stanwell Road
Feltham
Middlesex TW14 8NX
United Kingdom
Tel.: +44 (0) 20 8818 7200
Fax: +44 (0) 20 8818 7267

MEDIA RELATIONS

9, chemin des Mines
Case Postale 54
CH- 1211 Genève 20

Switchboard:

Tel.: +41-22-414 30 00

SERVICES